Showing results (451-460 of 520) with videos related to

Sort By:
Pageof 52
Journal of Oncology Practice|July 2, 2013
Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) projectBeatrice J Edwards, Sarah Usmani, Dennis W Raisch, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 14, 2020
Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort StudyFrederick Lansigan, Steven M Horwitz, Lauren C Pinter-Brown, et al.
Blood Advances|February 14, 2025
Phase 1 trial of durvalumab (anti-PD-L1) combined with lenalidomide in relapsed/refractory cutaneous T-cell lymphomaChristiane Querfeld, Joycelynne Palmer, Zhen Han, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptorS McLean, A Ganong, P A Seymour, et al.
The Journal of Investigative Dermatology|May 15, 2018
Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell LymphomaXu Hannah Zhang, Sangkil Nam, Jun Wu, et al.
Postgraduate Medicine|September 24, 1999
Safety of itraconazole pulse therapy for onychomycosis. An updateP De Doncker, A K Gupta, J Q Cel Rosso, et al.
Blood|December 12, 2018
Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphomaAtish Mohanty, Natalie Sandoval, An Phan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
The novel expanded porphyrin, motexafin gadolinium, combined with [90Y]ibritumomab tiuxetan for relapsed/refractory non-Hodgkin's lymphoma: preclinical findings and results of a phase I trialAndrew M Evens, William G Spies, Irene B Helenowski, et al.
Haematologica|July 18, 2024
Atezolizumab combined with immunogenic salvage chemoimmunotherapy in patients with transformed diffuse large B-cell lymphomaTamer Othman, Paul Frankel, Pamela Allen, et al.
Cancers|March 25, 2022
Synergy of Venetoclax and 8-Chloro-Adenosine in AML: The Interplay of rRNA Inhibition and Fatty Acid MetabolismDinh Hoa Hoang, Corey Morales, Ivan Rodriguez Rodriguez, et al.
Pageof 52